Search This Blog

Wednesday, May 27, 2026

Kaos Capital takes 4.9% stake in BioRestorative Therapies and urges board to launch strategic review

 


  • Kaos Capital asks the board to consider a potential pivot into AI as part of efforts to unlock shareholder value.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)